BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31729720)

  • 21. The role of carboxyhemoglobin measured with CO-oximetry in the detection of hemolysis in newborns with ABO alloimmunization.
    Lozar-Krivec J; Bratanic B; Paro-Panjan D
    J Matern Fetal Neonatal Med; 2016; 29(3):452-6. PubMed ID: 25604086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
    Schönitzer D; Frisch H
    Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia.
    Gamaleldin R; Iskander I; Seoud I; Aboraya H; Aravkin A; Sampson PD; Wennberg RP
    Pediatrics; 2011 Oct; 128(4):e925-31. PubMed ID: 21911352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morbidity of ABO haemolytic disease in the newborn.
    Bhat YR; Kumar CG
    Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [PROGNOSIS IN NEONATAL HEMOLYSIS CAUSED BY ABO INCOMPATIBILITY NOT TREATED WITH EXCHANGE TRANSFUSION. (PRELIMINARY REPORT)].
    FOHL E; LOMBOS O
    Orv Hetil; 1964 Nov; 105():2073-5. PubMed ID: 14228946
    [No Abstract]   [Full Text] [Related]  

  • 27. Haematolytic disease due to ABO incompatibility: incidence and value of screening in an Asian population.
    Han P; Kiruba R; Ong R; Joseph R; Tan KL; Wong HB
    Aust Paediatr J; 1988 Feb; 24(1):35-8. PubMed ID: 3355442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and etiology of neonatal hyperbilirubinemia.
    Sarici SU
    J Trop Pediatr; 2010 Apr; 56(2):128-9. PubMed ID: 19502601
    [No Abstract]   [Full Text] [Related]  

  • 29. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial difference in incidence of ABO hemolytic disease.
    Bucher KA; Patterson AM; Elston RC; Jones CA; Kirkman HN
    Am J Public Health; 1976 Sep; 66(9):854-8. PubMed ID: 961953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemolytic disease of the newborn due to incompatibility of the ABO system. Bilirubin encephalopathy].
    Malaguzzi Valeri O; Sbraccia C; Carapella De Luca E; Di Piero G; Mencarini L; Natoli G; Natoli V; Valeri OM
    Minerva Pediatr; 1967 Sep; 19(36):1678-86. PubMed ID: 5629556
    [No Abstract]   [Full Text] [Related]  

  • 32. ABO INCOMPATIBILITY IN THE NEWBORN: A REVIEW OF CASES AND CURRENT CONCEPTS.
    MITCHELL JR
    J Iowa Med Soc; 1964 May; 54():235-8. PubMed ID: 14143966
    [No Abstract]   [Full Text] [Related]  

  • 33. [Frequency and titration of hemolytic activity of anti-A and anti-B antibodies in mothers of children with jaundice in YaoundĂ©, Cameroon].
    Sock DS; Kamdem SD; Boula A; Netongo PM
    Pan Afr Med J; 2020; 35():13. PubMed ID: 32341734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phototherapy in ABO hemolytic disease of the newborn infant.
    Kaplan E; Herz F; Scheye E; Robinson LD
    J Pediatr; 1971 Dec; 79(6):911-4. PubMed ID: 5132303
    [No Abstract]   [Full Text] [Related]  

  • 35. ABO hemolytic disease of the newborn. A retrospective analysis of 254 cases.
    Dufour DR; Monoghan WP
    Am J Clin Pathol; 1980 Mar; 73(3):369-73. PubMed ID: 7189092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cross-sectional study of haemolytic disease of the newborn in Uganda.
    Dhabangi A; Nankunda J; Okaba V; Nakubulwa S; Hume HA; Dzik WH; Heddle NM
    Vox Sang; 2022 Dec; 117(12):1398-1404. PubMed ID: 36342344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Icterus gravis in ABO incompatibility and bilirubin coupling disorders].
    Stur O
    Wien Med Wochenschr; 1970 May; 120(22):400-1. PubMed ID: 5534805
    [No Abstract]   [Full Text] [Related]  

  • 38. Indirect neonatal hyperbilirubinemia in hospitalized neonates on the Thai-Myanmar border: a review of neonatal medical records from 2009 to 2014.
    Thielemans L; Trip-Hoving M; Landier J; Turner C; Prins TJ; Wouda EMN; Hanboonkunupakarn B; Po C; Beau C; Mu M; Hannay T; Nosten F; Van Overmeire B; McGready R; Carrara VI
    BMC Pediatr; 2018 Jun; 18(1):190. PubMed ID: 29895274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.